Search results for "investments"
Article
Biotechnology Innovation and Growth in Israel
Israel’s dynamic venture capital market has delivered a stream of substantial investments in R&D. With increasing awareness of chronic diseases and a highly skilled workforce, Israel’s pharmaceutical …
Article
Addressing the Challenges in Downstream Processing Today and Tomorrow
Further, companies have made significant investments in manufacturing facilities, resulting in cell culture bioreactor capacities of 12,000–20,000L. The increasing volumes, cell densities, and protein…
Article
Pandemic Alters Policies and Practices for Drug Development and Regulation
Changes in agency leadership, in regulatory strategies, and in decisions by researchers and manufacturers on where and how to plan future investments are slated to alter drug development and oversight…
Article
Reimagining Affordable Biosimilars
Given this arduous journey from lab to market, it is no surprise that biologics demand significant investments, the burden of which ultimately falls on the patients.
Making biotherapeutics af…
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
Olivier Le Moal/Stock.Adobe.com
By Cynthia A. Challener
Facility and equipment design are important, but the team and its experience matter most.
Through its Operation Warp Speed pro…
Article
Nurturing Knowledge from Disparate Data Streams
Leveraging vast quantities of analytical data requires digitalization and platform integration.
By Cynthia A. Challener
jijomathai/stock.Adobe.comAnalytical instrument…
Article
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
This article highlights 15 years of changes in biopharmaceutical manufacturing.
By Ronald A. Rader, Eric La…
Article
Single-use Bioreactors Have Reached the Big Time
The decision to use disposable bioreactors is now driven by commercial rather than technological considerations.
By Cynthia A. Challener
Single-use bioreactors available from various vendors…
Article
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
Harnessing this strategy has facilitated the early identification of unsuitable/unstable cell lines, thus enabling effective investments of time and resources only on those cell lines that are appropr…
Article
Advanced Technologies Facilitate Scale-up and Technology Transfer
“Many of the recent investments at Pall have been driven by this expectation, and our new single-pass tangential flow filtration modules and systems and inline concentrator are examples of technologie…